Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 450 of 658 entries
View as:
Phase: N/A
Priority: Normal
Start: 10/31/09
End: 12/31/10
Due: 12/31/11
Phase: N/A
Priority: Normal
Start: 02/05/18
End: 11/08/19
Due: 11/08/20
Phase: N/A
Priority: Normal
Start: 06/30/20
End: 01/10/24
Due: 01/10/25
Phase: N/A
Priority: Normal
Start: 01/31/08
End: 08/31/08
Due: 08/31/09
Phase: N/A
Priority: Normal
Start: 02/29/16
End: 03/31/21
Due: 03/31/22
Phase: N/A
Priority: Normal
Start: 02/29/16
End: 02/02/18
Due: 02/02/19
Phase: N/A
Priority: Normal
Start: 09/18/17
End: 10/01/23
Due: 10/01/24
Phase: N/A
Priority: Normal
Start: 10/31/11
End: 10/31/12
Due: 10/31/13
Phase: N/A
Priority: Normal
Start: 05/01/22
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 01/31/09
End: 12/31/09
Due: 12/31/10
Phase: N/A
Priority: Normal
Start: 10/31/11
End: 09/30/16
Due: 09/30/17
Phase: N/A
Priority: Normal
Start: 08/17/21
End: 03/17/27
Due: 03/17/28
Phase: N/A
Priority: Normal
Start: 03/31/16
End: 07/31/16
Due: 07/31/17
Clinical Characteristics of Parkinson's Disease Subjects With Severe Hypertension During Motor OFFs.
Phase: N/A
Priority: Normal
Start: 02/06/18
End: 12/31/22
Due: 12/31/23
Phase: N/A
Priority: Normal
Start: 05/31/09
End: 05/31/12
Due: 05/31/13
Phase: N/A
Priority: Normal
Start: 01/31/09
End: 05/31/14
Due: 05/31/15
Phase: N/A
Priority: Normal
Start: 03/31/07
End: 08/31/08
Due: 08/31/09
Phase: N/A
Priority: Normal
Start: 09/06/16
End: 01/08/18
Due: 01/08/19
Phase: N/A
Priority: Normal
Start: 02/08/05
End: 11/17/10
Due: 11/17/11
Phase: N/A
Priority: Normal
Start: 06/30/07
End: 12/31/10
Due: 12/31/11
Phase: N/A
Priority: Normal
Start: 12/31/10
End: 12/31/12
Due: 12/31/13
Phase: N/A
Priority: Normal
Start: 12/01/15
End: 09/15/19
Due: 09/15/20
Phase: N/A
Priority: Normal
Start: 06/01/17
End: 12/31/24
Due: 12/31/25
Phase: N/A
Priority: Normal
Start: 02/01/21
End: 08/25/22
Due: 08/25/23
Phase: N/A
Priority: Normal
Start: 06/30/05
End: -
Due: -